CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 67 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,137,735 | -36.2% | 6,943,654 | 0.0% | 0.22% | -25.3% |
| Q2 2023 | $15,900,968 | +151.6% | 6,943,654 | 0.0% | 0.29% | +132.3% |
| Q1 2023 | $6,318,725 | +7.1% | 6,943,654 | 0.0% | 0.12% | +9.7% |
| Q4 2022 | $5,902,106 | +3.9% | 6,943,654 | 0.0% | 0.11% | +7.6% |
| Q3 2022 | $5,683,000 | -17.3% | 6,943,654 | 0.0% | 0.10% | -16.0% |
| Q2 2022 | $6,875,000 | -39.6% | 6,943,654 | 0.0% | 0.12% | -32.4% |
| Q1 2022 | $11,388,000 | -31.9% | 6,943,654 | 0.0% | 0.18% | -14.0% |
| Q4 2021 | $16,734,000 | -50.2% | 6,943,654 | 0.0% | 0.22% | -41.7% |
| Q3 2021 | $33,607,000 | +56.3% | 6,943,654 | -13.8% | 0.37% | +70.0% |
| Q2 2021 | $21,502,000 | -13.3% | 8,053,298 | 0.0% | 0.22% | -6.5% |
| Q1 2021 | $24,804,000 | +3.0% | 8,053,298 | +19.0% | 0.23% | +10.0% |
| Q4 2020 | $24,093,000 | -11.2% | 6,767,584 | 0.0% | 0.21% | -38.1% |
| Q3 2020 | $27,138,000 | +47.4% | 6,767,584 | 0.0% | 0.34% | +31.7% |
| Q2 2020 | $18,408,000 | +28.9% | 6,767,584 | 0.0% | 0.26% | +7.9% |
| Q1 2020 | $14,280,000 | -61.2% | 6,767,584 | 0.0% | 0.24% | -54.4% |
| Q4 2019 | $36,816,000 | +80.7% | 6,767,584 | 0.0% | 0.53% | +35.9% |
| Q3 2019 | $20,370,000 | -17.0% | 6,767,584 | +3.1% | 0.39% | +1.8% |
| Q2 2019 | $24,556,000 | +2.4% | 6,565,685 | +10.0% | 0.38% | +2.4% |
| Q1 2019 | $23,990,000 | +9.5% | 5,967,584 | 0.0% | 0.37% | -8.4% |
| Q4 2018 | $21,901,000 | -57.2% | 5,967,584 | 0.0% | 0.40% | -34.4% |
| Q3 2018 | $51,202,000 | -21.9% | 5,967,584 | 0.0% | 0.62% | -21.0% |
| Q2 2018 | $65,524,000 | -4.8% | 5,967,584 | 0.0% | 0.78% | -8.4% |
| Q1 2018 | $68,806,000 | +23.5% | 5,967,584 | +10.9% | 0.85% | +21.0% |
| Q4 2017 | $55,730,000 | -35.0% | 5,379,349 | 0.0% | 0.70% | -13.9% |
| Q3 2017 | $85,747,000 | +31.7% | 5,379,349 | 0.0% | 0.82% | +20.1% |
| Q2 2017 | $65,090,000 | -41.7% | 5,379,349 | 0.0% | 0.68% | -46.1% |
| Q1 2017 | $111,729,000 | +45.2% | 5,379,349 | 0.0% | 1.27% | +29.2% |
| Q4 2016 | $76,925,000 | -13.1% | 5,379,349 | 0.0% | 0.98% | -2.8% |
| Q3 2016 | $88,490,000 | +15.4% | 5,379,349 | 0.0% | 1.01% | +26.0% |
| Q2 2016 | $76,710,000 | +0.6% | 5,379,349 | +2.3% | 0.80% | -0.2% |
| Q1 2016 | $76,248,000 | – | 5,258,450 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $2,683,000 | 0.74% |
| Telemetry Investments, L.L.C. | 522,009 | $427,000 | 0.55% |
| CHI Advisors LLC | 2,384,402 | $1,952,000 | 0.52% |
| Orbimed Advisors | 6,943,654 | $5,683,000 | 0.10% |
| BVF INC/IL | 1,370,947 | $1,122,000 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $52,000 | 0.02% |
| Artal Group S.A. | 500,000 | $409,000 | 0.02% |
| Hikari Power Ltd | 49,959 | $41,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $130,000 | 0.00% |
| Renaissance Technologies | 975,519 | $798,000 | 0.00% |